Search

everythinglearnresearchcommunity

for

Search:↓

Female donor to male recipient sex mismatch and positive ACA-IgG are key risk factors for vitiligo and alopecia areata in chronic GvHD patients.

South American camelids should be sheared early, fleece type affects fiber quality, and the S/P follicle ratio doesn't distinguish between Bolivian llama genotypes.

SCF and ET-1 together significantly increase skin pigmentation and melanin production.

Regenerative therapies show promise for treating vitiligo and alopecia areata.

Spanish experts provided guidelines for treating skin side effects in cancer patients on new therapies, stressing early action and teamwork.

Malnourished Andean Indian children had abnormal hair roots compared to healthy children.

Using 2% tofacitinib cream with narrowband ultraviolet B improved facial vitiligo by 70% in patients who didn't respond to previous treatments, with no side effects reported.

Intralesional triamcinolone acetonide can regrow hair in alopecia areata but often has temporary effects and side effects.

An 81-year-old man's white hair began to regain its original color while he was treated with lenalidomide, suggesting that graying hair might be reversible.

Treg dysfunction is linked to various autoimmune skin diseases, and understanding Treg properties is key for new treatments.

Genetic research has advanced our understanding of skin diseases, but complex conditions require an integrative approach for deeper insight.

Permanent hair loss from cicatricial alopecia is treated by reducing inflammation and managing symptoms, but regrowth in scarred areas is unlikely.

Apremilast did not work for treating severe alopecia areata.

Topical contact sensitizers can treat certain skin conditions but are rarely used in the U.K.

Hair restoration surgery can lead to swelling, infections, scarring, numbness, hiccups, and poor hair growth.

Different techniques for vitiligo treatment work similarly well, with some better for specific body areas.

Both genetic and lifestyle factors significantly affect female hair loss.

Hydroxychloroquine showed some potential, but overall, the three drugs had limited success in treating lupus in dogs.

Some drugs can cause skin and hair color changes, often reversible when the drug is stopped.

Quick treatment of hair disorders in teenage girls is important because of the emotional effects.

Most treatments for spondyloarthritis are safe, but monitoring and careful selection based on patient risks are important.

Chronic kidney disease can cause skin problems that affect patient quality of life, and treating these conditions can improve outcomes.

Using systemic drugs as creams for skin conditions shows promise, but more research is needed to confirm their effectiveness and safety.

New chemotherapy drugs cause skin side effects, but treatments like minocycline and tetracycline can help reduce them.

Anti-cancer treatments can cause reversible hair loss, skin sensitivity, pigmentation changes, nail damage, and skin reactions, with a need for more research on managing these side effects.

Tailor treatments for vitiligo to patient needs for best results.

Some alternative vitiligo treatments show promise, but none are as effective as psoralens and UVA.

The article concludes that correctly diagnosing systemic causes of hair loss requires a detailed clinical evaluation and a systematic diagnostic approach.

Early diagnosis and aggressive treatment are key for managing rare scalp disorders that cause permanent hair loss.

Lupus can cause hair loss and nail changes, with treatments available for both.